Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Psychiatry Investig ; 19(3): 171-177, 2022 Mar.
Article in English | MEDLINE | ID: mdl-35196827

ABSTRACT

OBJECTIVE: To explore the impact of the participation of patients with chronic mental illness in health promotion activities on their physical, psychological, and social functions. METHODS: This study included inpatient with chronic mental illness from a hospital in Eastern Taiwan. According to the experimental research design, the selected subjects were randomly divided into a health promotion group and a control group, with 60 people in each group. The health promotion team conducts health promotion activities twice a week, each for approximately 50 minutes, over the course of eight weeks (16 times in total). The measurement instrument adopts the Adult Mental Health Scale (AMHS) scale. Five experts and scholars in related fields are invited to conduct expert validity. RESULTS: Using independent sample t-tests to analyze the changes in the two groups after 8 weeks, the physical, psychological and social problems of the health promotion group were significantly improved compared with the control group. CONCLUSION: Health promotion activities can alleviate the physical illness, anxiety, irritability, depression, and social distress of chronic hospitalized mental patients, and can also increase their positive and optimistic mood. It can provide chronic mental health care institutions to plan patients' physical activities or exercises.

2.
Molecules ; 26(17)2021 Sep 02.
Article in English | MEDLINE | ID: mdl-34500769

ABSTRACT

Ergosta-7,9(11),22-trien-3ß-ol (EK100) was isolated from the Taiwan-specific medicinal fungus Antrodia camphorata, which is known for its health-promotion and anti-aging effects in folk medicine. Alzheimer's disease (AD) is a major aging-associated disease. We investigated the efficacy and potential mechanism of ergosta-7,9(11),22-trien-3ß-ol for AD symptoms. Drosophila with the pan-neuronal overexpression of human amyloid-ß (Aß) was used as the AD model. We compared the life span, motor function, learning, memory, oxidative stress, and biomarkers of microglia activation and inflammation of the ergosta-7,9(11),22-trien-3ß-ol-treated group to those of the untreated control. Ergosta-7,9(11),22-trien-3ß-ol treatment effectively improved the life span, motor function, learning, and memory of the AD model compared to the untreated control. Biomarkers of microglia activation and inflammation were reduced, while the ubiquitous lipid peroxidation, catalase activity, and superoxide dismutase activity remained unchanged. In conclusion, ergosta-7,9(11),22-trien-3ß-ol rescues AD deficits by modulating microglia activation but not oxidative stress.


Subject(s)
Alzheimer Disease/drug therapy , Microglia/drug effects , Neuroprotective Agents/pharmacology , Alzheimer Disease/metabolism , Amyloid beta-Peptides/antagonists & inhibitors , Amyloid beta-Peptides/metabolism , Animals , Disease Models, Animal , Drosophila , Humans , Microglia/metabolism , Neuroprotective Agents/chemistry , Neuroprotective Agents/isolation & purification , Polyporales/chemistry
3.
Free Radic Biol Med ; 165: 368-384, 2021 03.
Article in English | MEDLINE | ID: mdl-33460768

ABSTRACT

Emerging evidences implicate the contribution of ROS to T cell activation and signaling. The tyrosine kinase, ζ-chain-associated protein of 70 kDa (ZAP70), is essential for T cell development and activation. However, it remains elusive whether a direct redox regulation affects ZAP70 activity upon TCR stimulation. Here, we show that deficiency of non-selenocysteine containing phospholipid hydroperoxide glutathione peroxidase (NPGPx), a redox sensor, results in T cell hyperproliferation and elevated cytokine productions. T cell-specific NPGPx-knockout mice reveal enhanced T-dependent humoral responses and are susceptible to experimental autoimmune encephalomyelitis (EAE). Through proteomic approaches, ZAP70 is identified as the key interacting protein of NPGPx through disulfide bonding. NPGPx is activated by ROS generated from TCR stimulation, and modulates ZAP70 activity through redox switching to reduce ZAP70 recruitment to TCR/CD3 complex in membrane lipid raft, therefore subduing TCR responses. These results reveal a delicate redox mechanism that NPGPx serves as a modulator to curb ZAP70 functions in maintaining T cell homeostasis.


Subject(s)
Proteomics , T-Lymphocytes , Animals , Homeostasis , Mice , Oxidation-Reduction , Receptors, Antigen, T-Cell/genetics , Receptors, Antigen, T-Cell/metabolism , Signal Transduction , T-Lymphocytes/metabolism
4.
Cell Rep ; 29(8): 2134-2143.e7, 2019 Nov 19.
Article in English | MEDLINE | ID: mdl-31747588

ABSTRACT

Amyotrophic lateral sclerosis (ALS), the most common motor neuron disease, usually occurs in middle-aged people. However, the molecular basis of age-related cumulative stress in ALS pathogenesis remains elusive. Here, we found that mice deficient in NPGPx (GPx7), an oxidative stress sensor, develop ALS-like phenotypes, including paralysis, muscle denervation, and motor neurons loss. Unlike normal spinal motor neurons that exhibit elevated O-GlcNAcylation against age-dependent oxidative stress, NPGPx-deficient spinal motor neurons fail to boost O-GlcNAcylation and exacerbate ROS accumulation, leading to cell death. Mechanistically, stress-activated NPGPx inhibits O-GlcNAcase (OGA) through disulfide bonding to fine-tune global O-GlcNAcylation. Pharmacological inhibition of OGA rescues spinal motor neuron loss in aged NPGPx-deficient mice. Furthermore, expression of NPGPx in ALS patients is significantly lower than in unaffected adults. These results suggest that NPGPx modulates O-GlcNAcylation by inhibiting OGA to cope with age-dependent oxidative stress and protect motor neurons from degeneration, providing a potential therapeutic axis for ALS.


Subject(s)
Motor Neurons/metabolism , Oxidative Stress/physiology , beta-N-Acetylhexosaminidases/metabolism , Aging/physiology , Amyotrophic Lateral Sclerosis/metabolism , Animals , Female , Humans , Mice , Mice, Mutant Strains , Muscle Denervation , Oxidative Stress/genetics , Paralysis/metabolism
5.
Pol J Microbiol ; 67(3): 297-305, 2018.
Article in English | MEDLINE | ID: mdl-30451446

ABSTRACT

Soybean meal is the main vegetable protein source in animal feed. Soybean meal contains several anti-nutritional factors, which directly affect digestion and absorption of soy protein, thereby reducing growth performance and value in animals. Fermented soybean meal is rich in probiotics and functional metabolites, which facilitates soybean protein digestion, absorption and utilization in piglets. However, the mixed solid-state fermentation (SSF) conditions of soybean meal remain to be optimized. In this study, we investigated the optimal parameters for SSF of soybean meal by Lactobacillus species and Clostridium butyricum . The results showed that two days of fermentation was sufficient to increase the viable count of bacteria, lactic acid levels and degradation of soybean protein in fermented soybean meal at the initial moisture content of 50%. The pH value, lowering sugar content and oligosaccharides in fermented soybean meal, was significantly reduced at the initial moisture content of 50% after two days of fermentation. Furthermore, the exogenous proteases used in combination with probiotics supplementation were further able to enhance the viable count of bacteria, degradation of soybean protein and lactic acid level in the fermented soybean meal. In addition, the pH value and sugar content in fermented soybean meal were considerably reduced in the presence of both proteases and probiotics. Furthermore, the fermented soybean meal also showed antibacterial activity against Staphylococcus aureus and Escherichia coli . These results together suggest that supplementation of both proteases and probiotics in SSF improves the nutritional value of fermented soybean meal and this is suitable as a protein source in animal feed.


Subject(s)
Animal Feed/microbiology , Clostridium butyricum/metabolism , Fermentation , Glycine max , Lactobacillus/metabolism , Lactic Acid/analysis , Microbial Viability , Peptide Hydrolases/metabolism , Probiotics/metabolism
6.
J Exp Bot ; 69(22): 5389-5401, 2018 11 26.
Article in English | MEDLINE | ID: mdl-30165491

ABSTRACT

As key mediators linking developmental processes with plant immunity, TCP (TEOSINTE-BRANCHED, CYCLOIDEA, PROLIFERATION FACTOR 1 and 2) transcription factors have been increasingly shown to be targets of pathogenic effectors. We report here that TB/CYC (TEOSINTE-BRANCHED/CYCLOIDEA)-TCPs are destabilized by phytoplasma SAP11 effectors, leading to the proliferation of axillary meristems. Although a high degree of sequence diversity was observed among putative SAP11 effectors identified from evolutionarily distinct clusters of phytoplasmas, these effectors acquired fundamental activity in destabilizing TB/CYC-TCPs. In addition, we demonstrate that miR156/SPLs and miR172/AP2 modules, which represent key regulatory hubs involved in plant phase transition, were modulated by Aster Yellows phytoplasma strain Witches' Broom (AY-WB) protein SAP11. A late-flowering phenotype with significant changes in the expression of flowering-related genes was observed in transgenic Arabidopsis plants expressing SAP11AYWB. These morphological and molecular alterations were correlated with the ability of SAP11 effectors to destabilize CIN (CINCINNATA)-TCPs. Although not all putative SAP11 effectors display broad-spectrum activities in modulating morphological and physiological changes in host plants, they serve as core virulence factors responsible for the witches' broom symptom caused by phytoplasmas.


Subject(s)
Arabidopsis Proteins/genetics , Arabidopsis/genetics , Phytoplasma/physiology , Transcription Factors/genetics , Arabidopsis/anatomy & histology , Arabidopsis/metabolism , Arabidopsis/virology , Arabidopsis Proteins/metabolism , MicroRNAs/genetics , MicroRNAs/metabolism , Phytoplasma/genetics , Plant Immunity/genetics , Plants, Genetically Modified/anatomy & histology , Plants, Genetically Modified/genetics , Plants, Genetically Modified/metabolism , Plants, Genetically Modified/virology , Transcription Factors/metabolism , Virulence Factors
7.
J Exp Bot ; 67(14): 4415-25, 2016 07.
Article in English | MEDLINE | ID: mdl-27279277

ABSTRACT

Phytoplasmas are bacterial phytopathogens that release virulence effectors into sieve cells and act systemically to affect the physiological and morphological state of host plants to promote successful pathogenesis. We show here that transgenic Nicotiana benthamiana lines expressing the secreted effector SAP11 from Candidatus Phytoplasma mali exhibit an altered aroma phenotype. This phenomenon is correlated with defects in the development of glandular trichomes and the biosynthesis of 3-isobutyl-2-methoxypyrazine (IBMP). IBMP is a volatile organic compound (VOC) synthesized by an O-methyltransferase, via a methylation step, from a non-volatile precursor, 3-isobutyl-2-hydroxypyrazine (IBHP). Based on comparative and functional genomics analyses, NbOMT1, which encodes an O-methyltransferase, was found to be highly suppressed in SAP11-transgenic plants. We further silenced NbOMT1 through virus-induced gene silencing and demonstrated that this enzyme influenced the accumulation of IBMP in N. benthamiana In vitro biochemical analyses also showed that NbOMT1 can catalyse IBHP O-methylation in the presence of S-adenosyl-L-methionine. Our study suggests that the phytoplasma effector SAP11 has the ability to modulate host VOC emissions. In addition, we also demonstrated that SAP11 destabilized TCP transcription factors and suppressed jasmonic acid responses in N. benthamiana These findings provide valuable insights into understanding how phytoplasma effectors influence plant volatiles.


Subject(s)
Methyltransferases/metabolism , Nicotiana/microbiology , Phytoplasma/metabolism , Plant Proteins/metabolism , Pyrazines/metabolism , Blotting, Western , Methyltransferases/genetics , Phylogeny , Plants, Genetically Modified , Reverse Transcriptase Polymerase Chain Reaction , Nicotiana/metabolism , Trichomes/metabolism , Trichomes/physiology
8.
Plant Physiol ; 164(3): 1456-69, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24464367

ABSTRACT

Phytoplasmas have the smallest genome among bacteria and lack many essential genes required for biosynthetic and metabolic functions, making them unculturable, phloem-limited plant pathogens. In this study, we observed that transgenic Arabidopsis (Arabidopsis thaliana) expressing the secreted Aster Yellows phytoplasma strain Witches' Broom protein11 shows an altered root architecture, similarly to the disease symptoms of phytoplasma-infected plants, by forming hairy roots. This morphological change is paralleled by an accumulation of cellular phosphate (Pi) and an increase in the expression levels of Pi starvation-induced genes and microRNAs. In addition to the Pi starvation responses, we found that secreted Aster Yellows phytoplasma strain Witches' Broom protein11 suppresses salicylic acid-mediated defense responses and enhances the growth of a bacterial pathogen. These results contribute to an improved understanding of the role of phytoplasma effector SAP11 and provide new insights for understanding the molecular basis of plant-pathogen interactions.


Subject(s)
Arabidopsis/immunology , Arabidopsis/microbiology , Bacterial Proteins/metabolism , Phosphates/deficiency , Phytoplasma/metabolism , Anthocyanins/metabolism , Arabidopsis/drug effects , Arabidopsis/genetics , Base Sequence , Gene Expression Profiling , Gene Expression Regulation, Plant/drug effects , Genome, Plant/genetics , Homeostasis/drug effects , Homeostasis/genetics , Indoleacetic Acids/pharmacology , MicroRNAs/genetics , MicroRNAs/metabolism , Molecular Sequence Annotation , Molecular Sequence Data , Phenotype , Phytoplasma/drug effects , Plant Diseases/microbiology , Plant Growth Regulators/metabolism , Plant Immunity/drug effects , Plant Immunity/genetics , Plant Leaves/anatomy & histology , Plant Leaves/drug effects , Plant Leaves/genetics , Plant Roots/anatomy & histology , Plant Roots/drug effects , Plant Roots/metabolism , Plants, Genetically Modified , Pseudomonas syringae/drug effects , Pseudomonas syringae/physiology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Signal Transduction/drug effects , Signal Transduction/genetics
9.
Plant Sci ; 213: 46-54, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24157207

ABSTRACT

CDGSH iron-sulfur domain-containing proteins (CISDs) are newly discovered proteins with electron-accepting and electron-donating moieties. Although the CISDs of plants and animals show high sequence similarity in their CDGSH domain at the C-terminus, their N-terminal peptides have low sequence homology. Here, we show that At-NEET, a recently identified Arabidopsis CISD, contains a cleavable N-terminal peptide for chloroplast targeting, which is different from the uncleavable N-terminal peptide of mammal CISDs for mitochondrial outer membrane localization. Using affinity purification to isolate endogenous At-NEET, we identified a consensus sequence for the chloroplast transit peptide cleavage site of V-[R/K]↓A-E in At-NEET as well as other plant CISDs. Moreover, chloroplast subfractionation and immunogold labeling experiments showed that At-NEET localizes to the stroma of chloroplast. In addition, biochemical characterization revealed that At-NEET contains a conserved Cys(3)-His(1) ligand in the CDGSH domain, which is essential for coordination of 2Fe-2S clusters and protein folding. Our findings suggest that plant and animal CISDs contain an evolutionarily conserved CDGSH domain. However, they show different subcellular localization patterns that may result in distinct physiological functions.


Subject(s)
Antibodies/immunology , Arabidopsis/metabolism , Chloroplasts/metabolism , Iron-Sulfur Proteins/metabolism , Protein Processing, Post-Translational , Amino Acid Motifs , Amino Acid Sequence , Animals , Arabidopsis/genetics , Arabidopsis/ultrastructure , Arabidopsis Proteins/genetics , Arabidopsis Proteins/metabolism , Biological Transport , Chloroplast Proteins/genetics , Chloroplast Proteins/metabolism , Chloroplasts/ultrastructure , Cysteine/metabolism , Genes, Reporter , Iron-Sulfur Proteins/genetics , Iron-Sulfur Proteins/isolation & purification , Molecular Sequence Data , Plant Leaves/genetics , Plant Leaves/metabolism , Plant Leaves/ultrastructure , Plants, Genetically Modified , Protein Sorting Signals/genetics , Rabbits , Recombinant Proteins , Seedlings/genetics , Seedlings/metabolism , Seedlings/ultrastructure , Sequence Alignment , Sequence Deletion
10.
J Nutr ; 133(2): 483-8, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12566488

ABSTRACT

Two growth experiments were conducted to estimate the minimum dietary iron requirement for juvenile hybrid tilapia, Oreochromis niloticus x O. aureus. Purified diets containing 0, 10, 30, 50, 100, 150, 200 and 400 mg Fe/kg from ferric citrate (Experiment 1) and 0, 10, 30, 50, 100, 150 and 200 mg Fe/kg from ferrous sulfate (Experiment 2) were fed to tilapia (mean initial weight: 0.63 +/- 0.01 g, Experiment 1; 0.64 +/- 0.01 g, Experiment 2) for 8 wk. In Experiment 2, 150 mg Fe/kg from ferric citrate was also included for comparison. The rearing water contained 1.07 micro mol/L iron, and supplemental levels were confirmed by analysis. Each diet was fed to three replicate groups of fish. In Experiment 1, weight gain and feed efficiency (FE) were highest (P < 0.05) in fish fed the diet supplemented with 150 mg Fe/kg, followed by fish fed diets with 50, 100 and 200 mg Fe/kg and lowest in fish fed the unsupplemented control diet. Hepatic iron concentration was highest in fish fed diets supplemented with >150 mg Fe/kg, followed by fish fed the diet with 100 mg Fe/kg and lowest in fish fed diets with /=100 mg Fe/kg and mean corpuscular volume (MCV) and mean corpuscular hemoglobin (MCH) were higher in fish fed diets with >/=150 mg Fe/kg than in fish fed the diet without iron supplementation. In Experiment 2, weight gain was higher in fish fed the diet with 50 mg Fe/kg than in fish fed diets with 150, 200 and /=50 mg Fe/kg and the ferric citrate comparison diet than fish fed diets with /=50 mg Fe/kg than in fish fed the unsupplemented control diet. Analyses by polynomial regression of weight gain and by broken-line regression of hepatic iron and blood Hb concentrations indicated that the dietary iron requirement for tilapia is approximately 150-160 mg Fe/kg and 85 mg Fe/kg with ferric citrate and ferrous sulfate as the iron source, respectively; it also appears that ferric citrate was approximately 50% as effective as ferrous sulfate in meeting the iron requirement.


Subject(s)
Ferric Compounds/pharmacology , Ferrous Compounds/pharmacology , Iron/blood , Weight Gain/drug effects , Animals , Diet , Dose-Response Relationship, Drug , Ferric Compounds/administration & dosage , Ferrous Compounds/administration & dosage , Liver/metabolism , Male , Nutritional Requirements , Tilapia
SELECTION OF CITATIONS
SEARCH DETAIL
...